E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy

Kalshetty Shivaleela, M Pradeep Kumar.

Abstract
Background: Glaucoma is the second most common cause of blindness worldwide and also in India and its prevalence is increasing. Raised intraocular pressure (IOP) is most important and directly related to development of primary open-angle glaucoma (POAG). Hence, the present study carried out to compare the efficacy between latanoprost and dorzolamide for reducing IOP in POAG as monotherapy.

Aims and Objectives: The objectives are as follows: (i) To compare the efficacy between topical latanoprost (0.005%) and topical dorzolamide (2%) in POAG as monotherapy, and (ii) to evaluate the adverse effects of latanoprost and dorzolamide.

Materials and Methods: The present prospective, open-labeled study was conducted in 80 patients males and females which were selected randomly with POAG diagnosis and divided into two groups. One group received latanoprost (0.005%) topical eye drops once a day and other group received dorzolamide (2%) eye drops 3 times a day. All participants were followed up for three visits at 2 weeks, 4 weeks, and 8 weeks. Before starting on treatment baseline, IOP was recorded by Perkins Hand Held Tonometer. Again during each follow-up visit, IOP was recorded to know the response of drugs. The informed consent was taken from all patients and ethical clearance was taken from institution.

Results: The mean IOP reduction for latanoprost group was 9.5 ± 3.56 and dorzolamide group was 7.89 ± 3.56. Both drugs were effective in reducing IOP. The difference in IOP reduction between latanoprost and dorzolamide was statistically significant (P = 0.02). Both drugs were well tolerated during study period, maximum side effects seen in latanoprost group (n = 9) compared to dorzolamide group (n = 7).

Conclusion: The present study concludes that both latanoprost (0.005%) and dorzolamide (2%) topical eye drops effectively reduce IOP in POAG. The latanoprost is more efficacious compared to dorzolamide in reducing IOP.

Key words: Glaucoma; Intraocular Pressure; Latanoprost; Dorzolamide


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Kalshetty Shivaleela
Articles by M Pradeep Kumar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Shivaleela K, Kumar MP. Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. Natl J Physiol Pharm Pharmacol. 2020; 10(2): 134-140. doi:10.5455/njppp.2020.10.0931530112019


Web Style

Shivaleela K, Kumar MP. Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. http://www.njppp.com/?mno=61614 [Access: October 01, 2020]. doi:10.5455/njppp.2020.10.0931530112019


AMA (American Medical Association) Style

Shivaleela K, Kumar MP. Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. Natl J Physiol Pharm Pharmacol. 2020; 10(2): 134-140. doi:10.5455/njppp.2020.10.0931530112019



Vancouver/ICMJE Style

Shivaleela K, Kumar MP. Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. Natl J Physiol Pharm Pharmacol. (2020), [cited October 01, 2020]; 10(2): 134-140. doi:10.5455/njppp.2020.10.0931530112019



Harvard Style

Shivaleela, K. & Kumar, . M. P. (2020) Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. Natl J Physiol Pharm Pharmacol, 10 (2), 134-140. doi:10.5455/njppp.2020.10.0931530112019



Turabian Style

Shivaleela, Kalshetty, and M Pradeep Kumar. 2020. Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. National Journal of Physiology, Pharmacy and Pharmacology, 10 (2), 134-140. doi:10.5455/njppp.2020.10.0931530112019



Chicago Style

Shivaleela, Kalshetty, and M Pradeep Kumar. "Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 134-140. doi:10.5455/njppp.2020.10.0931530112019



MLA (The Modern Language Association) Style

Shivaleela, Kalshetty, and M Pradeep Kumar. "Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy." National Journal of Physiology, Pharmacy and Pharmacology 10.2 (2020), 134-140. Print. doi:10.5455/njppp.2020.10.0931530112019



APA (American Psychological Association) Style

Shivaleela, K. & Kumar, . M. P. (2020) Comparative study of efficacy of latanoprost (0.005%) and dorzolamide (2%), in primary open-angle glaucoma patients, as monotherapy. National Journal of Physiology, Pharmacy and Pharmacology, 10 (2), 134-140. doi:10.5455/njppp.2020.10.0931530112019